 Jeniann Yi
Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 8 | 2023 | 259 | 3.020 |
Why?
| | Endovascular Procedures | 7 | 2023 | 269 | 2.180 |
Why?
| | Blood Vessel Prosthesis Implantation | 4 | 2023 | 181 | 1.720 |
Why?
| | Operating Rooms | 2 | 2023 | 86 | 1.520 |
Why?
| | Aortic Aneurysm, Thoracic | 2 | 2023 | 122 | 1.460 |
Why?
| | Kidney Failure, Chronic | 2 | 2023 | 489 | 1.100 |
Why?
| | Sexism | 2 | 2023 | 44 | 0.950 |
Why?
| | Thrombosis | 3 | 2023 | 298 | 0.940 |
Why?
| | Peripheral Vascular Diseases | 2 | 2022 | 97 | 0.940 |
Why?
| | Pandemics | 4 | 2022 | 1317 | 0.890 |
Why?
| | Racism | 2 | 2023 | 102 | 0.850 |
Why?
| | Carotid Stenosis | 1 | 2023 | 79 | 0.850 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 88 | 0.800 |
Why?
| | Congresses as Topic | 1 | 2023 | 195 | 0.800 |
Why?
| | Surgeons | 3 | 2023 | 239 | 0.780 |
Why?
| | Spinal Cord Ischemia | 1 | 2022 | 63 | 0.770 |
Why?
| | Salaries and Fringe Benefits | 1 | 2021 | 52 | 0.750 |
Why?
| | Cost Savings | 1 | 2021 | 74 | 0.740 |
Why?
| | Renal Dialysis | 2 | 2023 | 374 | 0.730 |
Why?
| | Physicians, Women | 1 | 2021 | 55 | 0.720 |
Why?
| | Personnel Selection | 1 | 2021 | 62 | 0.710 |
Why?
| | Medical Informatics | 1 | 2021 | 90 | 0.710 |
Why?
| | Efficiency, Organizational | 1 | 2021 | 125 | 0.710 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 234 | 0.670 |
Why?
| | Peripheral Arterial Disease | 2 | 2022 | 380 | 0.640 |
Why?
| | Administrative Claims, Healthcare | 1 | 2018 | 22 | 0.620 |
Why?
| | Quality Improvement | 3 | 2022 | 950 | 0.620 |
Why?
| | Hospital Charges | 1 | 2018 | 39 | 0.620 |
Why?
| | Treatment Outcome | 12 | 2023 | 9088 | 0.600 |
Why?
| | Reimbursement Mechanisms | 1 | 2018 | 77 | 0.600 |
Why?
| | Stroke | 2 | 2023 | 1021 | 0.580 |
Why?
| | Thoracic Outlet Syndrome | 1 | 2016 | 12 | 0.560 |
Why?
| | Research Design | 1 | 2022 | 928 | 0.550 |
Why?
| | Ribs | 1 | 2016 | 29 | 0.550 |
Why?
| | Electronic Health Records | 1 | 2023 | 800 | 0.540 |
Why?
| | Incidental Findings | 1 | 2016 | 70 | 0.530 |
Why?
| | Osteotomy | 2 | 2018 | 146 | 0.530 |
Why?
| | Vascular Malformations | 1 | 2016 | 47 | 0.520 |
Why?
| | Stents | 4 | 2023 | 475 | 0.520 |
Why?
| | Lymph | 1 | 2015 | 40 | 0.490 |
Why?
| | Health Care Costs | 1 | 2018 | 381 | 0.490 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 70 | 0.490 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 199 | 0.430 |
Why?
| | Humans | 30 | 2023 | 114655 | 0.410 |
Why?
| | Retrospective Studies | 8 | 2023 | 12545 | 0.400 |
Why?
| | Workflow | 2 | 2023 | 133 | 0.380 |
Why?
| | Adenocarcinoma | 2 | 2020 | 795 | 0.380 |
Why?
| | Risk Factors | 6 | 2023 | 8631 | 0.350 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 388 | 0.290 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2285 | 0.290 |
Why?
| | Sex Factors | 2 | 2023 | 1715 | 0.280 |
Why?
| | Colorectal Neoplasms | 1 | 2012 | 615 | 0.260 |
Why?
| | Postoperative Hemorrhage | 2 | 2016 | 74 | 0.250 |
Why?
| | Databases, Factual | 3 | 2018 | 1125 | 0.230 |
Why?
| | Graft Occlusion, Vascular | 1 | 2023 | 35 | 0.210 |
Why?
| | Vascular Patency | 1 | 2023 | 97 | 0.210 |
Why?
| | Constriction, Pathologic | 1 | 2023 | 208 | 0.210 |
Why?
| | Median Arcuate Ligament Syndrome | 1 | 2022 | 1 | 0.210 |
Why?
| | Enoxaparin | 1 | 2023 | 52 | 0.210 |
Why?
| | Iliac Aneurysm | 1 | 2022 | 17 | 0.210 |
Why?
| | Patients | 1 | 2023 | 163 | 0.200 |
Why?
| | Time Factors | 3 | 2022 | 6115 | 0.200 |
Why?
| | Dyslipidemias | 1 | 2023 | 154 | 0.200 |
Why?
| | Arteries | 1 | 2023 | 247 | 0.200 |
Why?
| | Female | 10 | 2023 | 59489 | 0.190 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2022 | 113 | 0.190 |
Why?
| | Root Cause Analysis | 1 | 2021 | 8 | 0.190 |
Why?
| | Human Rights | 1 | 2021 | 15 | 0.190 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 249 | 0.190 |
Why?
| | Specialties, Surgical | 1 | 2022 | 70 | 0.180 |
Why?
| | Cultural Diversity | 1 | 2021 | 54 | 0.180 |
Why?
| | Embolization, Therapeutic | 1 | 2022 | 178 | 0.180 |
Why?
| | Burns, Electric | 1 | 2020 | 20 | 0.180 |
Why?
| | Health Plan Implementation | 1 | 2021 | 132 | 0.180 |
Why?
| | Iatrogenic Disease | 1 | 2020 | 49 | 0.170 |
Why?
| | Morbidity | 1 | 2021 | 280 | 0.170 |
Why?
| | Societies, Medical | 1 | 2023 | 663 | 0.170 |
Why?
| | Atherosclerosis | 1 | 2023 | 341 | 0.170 |
Why?
| | Male | 7 | 2023 | 55580 | 0.170 |
Why?
| | General Surgery | 1 | 2021 | 127 | 0.170 |
Why?
| | Patient Reported Outcome Measures | 1 | 2021 | 250 | 0.170 |
Why?
| | Aspirin | 1 | 2022 | 324 | 0.170 |
Why?
| | Foot | 1 | 2020 | 103 | 0.160 |
Why?
| | Catheterization, Central Venous | 1 | 2020 | 83 | 0.160 |
Why?
| | United States | 4 | 2023 | 12180 | 0.160 |
Why?
| | Ischemia | 1 | 2022 | 362 | 0.160 |
Why?
| | Intermittent Claudication | 1 | 2020 | 108 | 0.160 |
Why?
| | Infection Control | 1 | 2020 | 135 | 0.160 |
Why?
| | Tendons | 1 | 2020 | 120 | 0.160 |
Why?
| | Hyoid Bone | 1 | 2018 | 2 | 0.160 |
Why?
| | Current Procedural Terminology | 1 | 2018 | 11 | 0.160 |
Why?
| | Academic Medical Centers | 1 | 2021 | 411 | 0.160 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 15 | 0.160 |
Why?
| | Femoral Vein | 1 | 2018 | 28 | 0.160 |
Why?
| | Referral and Consultation | 1 | 2023 | 632 | 0.160 |
Why?
| | Nerve Compression Syndromes | 1 | 2018 | 25 | 0.160 |
Why?
| | Global Health | 1 | 2021 | 287 | 0.160 |
Why?
| | Colonic Neoplasms | 1 | 2020 | 215 | 0.160 |
Why?
| | Intracranial Embolism | 1 | 2018 | 29 | 0.150 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 243 | 0.150 |
Why?
| | Laparoscopy | 1 | 2022 | 398 | 0.150 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 401 | 0.150 |
Why?
| | Hematoma | 1 | 2018 | 49 | 0.150 |
Why?
| | Carotid Artery Injuries | 1 | 2018 | 44 | 0.150 |
Why?
| | Urban Health Services | 1 | 2018 | 60 | 0.150 |
Why?
| | Carotid Artery Diseases | 1 | 2018 | 57 | 0.150 |
Why?
| | Vena Cava, Inferior | 1 | 2018 | 56 | 0.150 |
Why?
| | Colorado | 2 | 2018 | 4099 | 0.150 |
Why?
| | Communication | 1 | 2023 | 744 | 0.150 |
Why?
| | Vena Cava Filters | 1 | 2018 | 50 | 0.150 |
Why?
| | Anticoagulants | 1 | 2022 | 550 | 0.150 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 430 | 0.150 |
Why?
| | Muscle Weakness | 1 | 2018 | 80 | 0.150 |
Why?
| | Rural Health Services | 1 | 2018 | 92 | 0.150 |
Why?
| | Running | 1 | 2020 | 207 | 0.150 |
Why?
| | Vascular System Injuries | 1 | 2018 | 66 | 0.150 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 228 | 0.140 |
Why?
| | Patient Readmission | 1 | 2023 | 610 | 0.140 |
Why?
| | Risk Assessment | 2 | 2023 | 2968 | 0.140 |
Why?
| | Program Evaluation | 1 | 2021 | 822 | 0.140 |
Why?
| | Venous Thrombosis | 1 | 2018 | 140 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2020 | 506 | 0.140 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 84 | 0.130 |
Why?
| | Comorbidity | 1 | 2021 | 1448 | 0.130 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 544 | 0.130 |
Why?
| | Alarmins | 1 | 2015 | 25 | 0.130 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 900 | 0.130 |
Why?
| | Hypertension | 1 | 2023 | 1056 | 0.130 |
Why?
| | Mesentery | 1 | 2015 | 53 | 0.130 |
Why?
| | Bacterial Translocation | 1 | 2015 | 36 | 0.130 |
Why?
| | Electrical Equipment and Supplies | 1 | 2015 | 8 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 338 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 330 | 0.120 |
Why?
| | Lower Extremity | 1 | 2018 | 335 | 0.120 |
Why?
| | Equipment Failure | 1 | 2015 | 106 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2021 | 833 | 0.120 |
Why?
| | Intraoperative Complications | 1 | 2015 | 122 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2021 | 1394 | 0.110 |
Why?
| | Telemedicine | 1 | 2022 | 662 | 0.110 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 219 | 0.110 |
Why?
| | Liver | 1 | 2020 | 1637 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 1727 | 0.100 |
Why?
| | Internship and Residency | 1 | 2021 | 926 | 0.100 |
Why?
| | Postoperative Complications | 1 | 2022 | 2128 | 0.100 |
Why?
| | Burns | 1 | 2015 | 237 | 0.100 |
Why?
| | Quality of Life | 1 | 2021 | 2353 | 0.090 |
Why?
| | Incidence | 1 | 2016 | 2312 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 1 | 2015 | 2218 | 0.090 |
Why?
| | Treatment Failure | 2 | 2022 | 331 | 0.080 |
Why?
| | Middle Aged | 4 | 2018 | 26733 | 0.080 |
Why?
| | Computed Tomography Angiography | 2 | 2018 | 97 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6345 | 0.070 |
Why?
| | Celiac Artery | 1 | 2022 | 9 | 0.050 |
Why?
| | Adult | 3 | 2023 | 30543 | 0.050 |
Why?
| | Ligaments | 1 | 2022 | 45 | 0.050 |
Why?
| | Heparin | 1 | 2023 | 224 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2023 | 218 | 0.050 |
Why?
| | Abdominal Pain | 1 | 2022 | 135 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2022 | 329 | 0.050 |
Why?
| | Arginase | 1 | 2020 | 27 | 0.040 |
Why?
| | Aged | 1 | 2018 | 19069 | 0.040 |
Why?
| | Tenotomy | 1 | 2020 | 13 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2020 | 228 | 0.040 |
Why?
| | Aorta | 1 | 2022 | 386 | 0.040 |
Why?
| | Tendon Transfer | 1 | 2020 | 43 | 0.040 |
Why?
| | Macrophage Activation | 1 | 2020 | 164 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 2020 | 93 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2021 | 287 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 249 | 0.040 |
Why?
| | Physical Endurance | 1 | 2020 | 232 | 0.040 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2018 | 39 | 0.040 |
Why?
| | Retroperitoneal Space | 1 | 2018 | 15 | 0.040 |
Why?
| | Animals | 2 | 2020 | 31698 | 0.040 |
Why?
| | Head Movements | 1 | 2018 | 17 | 0.040 |
Why?
| | Qualitative Research | 1 | 2023 | 934 | 0.040 |
Why?
| | Phlebography | 1 | 2018 | 34 | 0.040 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2018 | 33 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2020 | 539 | 0.040 |
Why?
| | Patient Positioning | 1 | 2018 | 42 | 0.040 |
Why?
| | Cerebral Angiography | 1 | 2018 | 109 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 83 | 0.040 |
Why?
| | Blood Vessel Prosthesis | 1 | 2018 | 112 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2020 | 498 | 0.040 |
Why?
| | Cryopreservation | 1 | 2018 | 92 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2021 | 578 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 295 | 0.040 |
Why?
| | Device Removal | 1 | 2018 | 126 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2021 | 368 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 668 | 0.040 |
Why?
| | Betacoronavirus | 1 | 2020 | 250 | 0.040 |
Why?
| | Reoperation | 1 | 2018 | 514 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 574 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 935 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 975 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2015 | 172 | 0.030 |
Why?
| | Fires | 1 | 2015 | 73 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2020 | 2710 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2380 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1183 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 4692 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 3531 | 0.020 |
Why?
| | Infant | 1 | 2023 | 7959 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 4407 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 4512 | 0.020 |
Why?
| | Mice | 1 | 2020 | 14863 | 0.010 |
Why?
| | Child | 1 | 2023 | 18407 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 17838 | 0.010 |
Why?
|
|
Yi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|